Complete proof-of-concept Phase 2a dataset of investigational HIV-1 Maturation Inhibitor presented at European AIDS Conference (EACS)
Complete Phase 2a Study of HIV-1 Investigational Maturation Inhibitor Demonstrates Positive Results for Therapy Designed to Attack Virus Differently Than Existing Treatments | BMS Newsroom
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.